John Bisi

Co-Founder/ Senior Vice President
North Carolina, United States

Professional Overview

John Bisi is the Co-Founder and Senior Vice President at Incyclix Bio, a biotechnology company focused on developing innovative cancer therapies. With over 20 years of experience in the pharmaceutical and biotech industries, he brings a wealth of expertise in preclinical research and development, with a strong focus on gene interference and cancer therapeutics.

Experience Summary

Current Role

As the Co-Founder and Senior Vice President of Incyclix Bio, John is responsible for leading the company's research and development efforts, overseeing the advancement of its pipeline of cancer treatments. He plays a pivotal role in driving the company's strategic vision, fostering cross-functional collaboration, and ensuring the successful execution of key projects.

Career Progression

Prior to co-founding Incyclix Bio, John served as the Senior Director of Preclinical Research and Development at G1 Therapeutics, Inc., where he led a team of researchers in the development of novel cancer therapies. Earlier in his career, he held the position of Investigator and Team Leader in Gene Interference at GlaxoSmithKline, where he contributed to the advancement of breakthrough therapeutic approaches.

Academic Background

John holds a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill, where he graduated with distinction.

Areas of Expertise

• Preclinical research and development

• Gene interference and cancer therapeutics

• Project management and cross-functional collaboration

• Strategic leadership in the biotechnology industry

Professional Impact

Throughout his career, John has played a pivotal role in the advancement of cancer research and the development of innovative therapeutic solutions. His work has resulted in the successful progression of multiple drug candidates through the preclinical stage, and he has contributed to the scientific community through his participation in industry conferences and publications.

Conclusion

With his extensive experience, strong technical expertise, and demonstrated leadership in the biotechnology industry, John Bisi is poised to continue driving transformative change in the field of cancer research and treatment as the Co-Founder and Senior Vice President of Incyclix Bio.